Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer

Front Med (Lausanne). 2023 Aug 31:10:1213136. doi: 10.3389/fmed.2023.1213136. eCollection 2023.

Abstract

Single-cell sequencing is a high-throughput technique that enables detection of genomic, transcriptomic, and epigenomic information at the individual cell level, offering significant advantages in detecting cellular heterogeneity, precise cell classification, and identifying rare subpopulations. The technique holds tremendous potential in improving the diagnosis and treatment of pancreatic cancer. Moreover, single-cell sequencing provides unique insights into the mechanisms of pancreatic cancer metastasis and cachexia, paving the way for developing novel preventive strategies. Overall, single-cell sequencing has immense potential in promoting early diagnosis, guiding personalized treatment, and preventing complications of pancreatic cancer. Emerging single-cell sequencing technologies will undoubtedly enhance our understanding of the complex biology of pancreatic cancer and pave the way for new directions in its clinical diagnosis and treatment.

Keywords: heterogeneity; microenvironment; pancreatic cancer; personalized therapy; single-cell sequencing.

Publication types

  • Review